Professor Marco Guerrini from Italy's Ronzoni Institute and his delegation visited Focusfreda.

On April 9, Professor Marco Guerrini, Director of the Ronzoni Institute for Chemistry and Biochemistry in Italy and a leading international expert in sugar chemistry, visited Focusfreda for a tour and exchange activity. Kang Chuanli, Deputy General Manager and R&D Director of Focusfreda, received the delegation, accompanied by Li Ququan, Human Resources Director, and Liu Qiang, Head of the Project Department.

Professor Marco Guerrini and his delegation visited Focusfreda's sodium hyaluronate production base, R&D center, and corporate exhibition hall in succession. At the production base, experts toured fermentation and purification workshops to gain firsthand insight into the full-process manufacturing workflow of sodium hyaluronate, offering high praise for Focusfreda's industrial capabilities in microbial fermentation, polysaccharide structural modification, and quality control. During the R&D center visit, experts focused on the technological innovation framework, core R&D priorities, and cutting-edge instrument platform development. The corporate exhibition hall provided a comprehensive overview of Focusfreda's growth trajectory, core technology systems, and global market presence through extensive visual materials and product displays.

Following the visit, both parties held a symposium for exchange. Kang Chuanli extended a warm welcome to Professor Marco Guerrini and provided a detailed introduction to the company's latest advancements in synthetic biology and green manufacturing. The two sides engaged in in-depth discussions on cutting-edge technologies in glycoside drug development, chassis cell optimization, metabolic engineering modifications, and technology transfer, exploring potential directions for future technological integration and collaborative projects.

As a leading global manufacturer of sodium hyaluronate, Focusfreda operates comprehensive production lines covering eye drop-grade, injectable-grade, food-grade, and cosmetic-grade products. The company holds production capabilities across pharmaceuticals, food, cosmetics, and medical devices, with certifications including ISO9001, BRC, and HALAL. Its products are exported to over 70 countries and regions. Recognized as a National Manufacturing Single Champion Demonstration Enterprise and a National Specialized, Refined, and Innovative "Little Giant" Enterprise, Focusfreda has established research platforms such as a National Postdoctoral Research Workstation and Shandong Provincial Enterprise Technology Center. The company holds 105 authorized patents, including 7 international invention patents.

During the symposium, Professor Marco Guerrini shared cutting-edge research achievements in the field of glycosides and introduced the core strengths of the Ronzoni Institute in polysaccharide structure analysis and innovative drug development. As an internationally renowned expert in glycochemistry, Professor Guerrini visited Freda and the Shandong Academy of Pharmaceutical Sciences last year, establishing a solid foundation for bilateral collaboration. During this revisit, both parties conducted more focused and in-depth technical discussions on the research and production practices of active glycoside raw materials such as hyaluronic acid and tremella polysaccharides.

In the future, Focusfreda will continue to uphold the development philosophy of open innovation, relying on synthetic biology and green biomanufacturing technologies to deepen industry-academia-research collaboration with top international research teams, accelerate the industrialization process of sugar-based drugs and bioactive raw materials, and contribute more China wisdom and Freda solutions to global health initiatives.